Study of Botulinum Toxin in Patients With Primary Hyperhidrosis
I. Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis.
|Study Design:||Primary Purpose: Treatment|
|Study Start Date:||July 1999|
Patients receive injections of botulinum toxin in the clinical trial for 6 months. Patients undergo an iodine starch test and a sympathetic skin response test to assess the efficacy of the drug. Patients also complete questionnaires to evaluate the amount of sweating.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004480
|United States, New York|
|Mount Sinai School of Medicine|
|New York, New York, United States, 10029|
|Study Chair:||Horacio Kaufmann||Icahn School of Medicine at Mount Sinai|